|
NASHVILLE, Tenn.--(BUSINESS WIRE)--April 6, 2005--Renal Care Group, Inc.
(NYSE:RCI) today announced the acquisition of three dialysis programs:
HemaCare Dialysis Center, based in Lansing, Michigan; Mid-Michigan Regional
Dialysis Center, based in East Lansing, Michigan; and Beaverton Dialysis
Center, based in Beaverton, Oregon. The three programs serve over 400
patients. The Company did not disclose terms of the transactions.
Gary Brukardt, president and chief executive officer of Renal Care Group,
commented, "With a full pipeline of acquisition opportunities, we continue
to add to our patient base and affiliate with physician leaders in our
key markets. We are pleased to begin working with each of these nephrology
practices to provide quality dialysis care."
Michael R. Hourani, M.D., P.C. will serve as medical director for the
Lansing facility. Lansing Nephrology Group, a division of Mid-Michigan
Physicians, P.C., will serve as medical director for the East Lansing
facility, and Donald W. Froom, M.D., P.C. will serve as medical director
for the Beaverton, Oregon facility.
Renal Care Group, Inc. is a specialized dialysis services company that
provides care to patients with kidney disease. The Company serves over
30,000 patients at more than 420 outpatient dialysis facilities, in addition
to providing acute dialysis services at more than 210 hospitals. Over
8,900 associates provide services across the Company's 34-state network.
More information about Renal Care Group, Inc. may be found at www.renalcaregroup.com.
Certain statements in this press release, particularly
those of Mr. Brukardt, constitute "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements, which are usually preceded by words like expect,
plan, intend, believe, will and the like, include statements that necessarily
depend on future events. These forward-looking statements reflect management's
expectations and are based upon currently available information. These
forward-looking statements involve known and unknown risks, uncertainties
and other factors that may cause actual results, performance or achievements
of Renal Care Group to differ materially from those expressed in or implied
by the forward-looking statements, including risks related to: the integration
of acquired companies; compliance with health care and other applicable
laws; changes in the Medicare and Medicaid programs; risks related to
the drug Epogen (EPO); payment reductions by private insurers, hospitals
or managed care organizations; and changes in the health care delivery,
financing or reimbursement systems. These and other factors affecting
the Company are discussed in more detail in Renal Care Group's reports
filed with the Securities and Exchange Commission, including without limitation
Renal Care Group's most recent annual report on Form 10-K and quarterly
reports on Form 10-Q filed after that annual report. Copies of these filings
are available from Renal Care Group upon request.
Contact:
Renal Care Group, Inc.
Terry Proveaux, 615-345-5577
www.renalcaregroup.com
|
Press Releases